Pediapharm Inc. (CVE:PDP – Get Free Report) shot up 1.7% on Thursday . The stock traded as high as C$0.31 and last traded at C$0.30. 26,000 shares traded hands during trading, a decline of 74% from the average session volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Stock Performance
The company has a market capitalization of C$66.36 million and a price-to-earnings ratio of -4.11. The company has a 50 day moving average price of C$0.30 and a 200 day moving average price of C$0.30. The company has a debt-to-equity ratio of 186.87, a quick ratio of 0.71 and a current ratio of 1.12.
About Pediapharm
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was incorporated in 2003 and is headquartered in Verdun, Canada.
Read More
- Five stocks we like better than Pediapharm
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
- Your Bank Account Is No Longer Safe
- He just nailed another gold prediction …
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
